1,020 filings
Page 18 of 51
EFFECT
93bqu10
22 May 19
Notice of effectiveness
12:15am
POS AM
33coi9mjqbxpk
21 May 19
Prospectus update (post-effective amendment)
9:11am
CORRESP
riyxcx
21 May 19
Correspondence with SEC
12:00am
D
tsudt7hyg4414ovpoak9
20 May 19
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
5:12pm
UPLOAD
wrib6fvwwztmpwt j8
20 May 19
Letter from SEC
12:00am
POS AM
ivfbvkzu4uc
17 May 19
Prospectus update (post-effective amendment)
5:25pm
POS AM
19ricrvl
14 May 19
Prospectus update (post-effective amendment)
11:55am
424B5
3gismdgknnad7lt4
13 May 19
Prospectus supplement for primary offering
4:14pm
8-K
op96sspuz
13 May 19
Trovagene Announces Equity Investment of $1.5 Million at Premium to Market Price
3:47pm
POS AM
ybljjcww
10 May 19
Prospectus update (post-effective amendment)
4:57pm
CORRESP
7dupz
10 May 19
Correspondence with SEC
12:00am
UPLOAD
mn94dqhk cqk44rw
9 May 19
Letter from SEC
12:00am
8-K
7omjtg 70h
8 May 19
Trovagene Announces First Quarter 2019 Results and Highlights
12:00am
POS AM
l1uz3unolhi9gre
25 Apr 19
Prospectus update (post-effective amendment)
12:00am
DEFA14A
t19lua
23 Apr 19
Additional proxy soliciting materials
4:05pm
8-K
tcdf0xwp9rf
23 Apr 19
Trovagene Announces Data Demonstrating Significant Synergy of Onvansertib in Combination with Venetoclax in Cell Model of Venetoclax-Resistant AML
2:39pm
D
whppn65j
10 Apr 19
$1.5M in equity / options / securities to be acquired, sold $1.5M, 1 investor
4:46pm
424B5
q7l009 5juo
5 Apr 19
Prospectus supplement for primary offering
3:41pm